|
Market Closed -
Nasdaq Stockholm
20:00:00 16/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,593.00 SEK | -0.06% |
|
+3.01% | -6.49% |
| 05:55pm | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 12:47pm | Daiichi and AstraZeneca cancer drugs secure further approvals in Japan | AN |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,324.87 | +16.61% | 29 | ||||||
| 277.91 | +4.01% | 22 | ||||||
| 278.61 | +5.92% | 28 | ||||||
| 374.61 | +3.88% | 19 | ||||||
| 153.05 | +10.12% | 22 | ||||||
| 211.86 | +29.67% | 23 | ||||||
| 388.03 | +3.3% | 29 | ||||||
| 310.17 | +12.42% | 23 | ||||||
| 158.15 | +8.1% | 27 | ||||||
| 28.88 | +4.81% | 26 | ||||||
| 569.19 | +10.6% | 27 | ||||||
| 66.71 | +4.67% | 24 | ||||||
| 94.06 | +26.75% | 24 | ||||||
| 21.71 | +17.1% | 21 | ||||||
| 9,323.33 | +43.44% | 15 | ||||||
| 6,603.31 | +12.94% | 16 | ||||||
| 58.22 | +19.53% | 18 | ||||||
| 71.35 | +65.44% | 17 | ||||||
| 4.202 | +23.42% | 17 | ||||||
| Average | 1,069.38 | +16.98% | 22 | ||||||
| Weighted average by Cap. | 716.17 | +12.12% | 25 |
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
